Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa A Jackson

Showing results (211-220 of 246) with videos related to

Pageof 25
Sort By:
The Journal of Infectious Diseases|January 24, 2018
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United StatesBrendan Flannery, Catherine Smith, Rebecca J Garten, et al.
Journal of the American Geriatrics Society|April 20, 2010
Workshop on immunizations in older adults: identifying future research agendasKevin P High, Richard T D'Aquila, Rebecca A Fuldner, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
MMWR. Morbidity and Mortality Weekly Report|February 15, 2019
Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019Joshua D Doyle, Jessie R Chung, Sara S Kim, et al.
Vaccine|July 6, 2015
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjectsSharon E Frey, Anna Wald, Srilatha Edupuganti, et al.
Science Translational Medicine|August 24, 2022
A genetically engineered <i>Plasmodium falciparum</i> parasite vaccine provides protection from controlled human malaria infectionSean C Murphy, Ashley M Vaughan, James G Kublin, et al.
NPJ Vaccines|June 2, 2026
Schistosomiasis vaccine SchistoShield® induces functional immune memory responses in US and African populationsMumtaz Y Balkhi, Aravindan Kalyanasundaram, Aryandra Arya, et al.
The Journal of Infectious Diseases|October 31, 2019
Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 SeasonBrendan Flannery, Rebecca J Garten Kondor, Jessie R Chung, et al.
Pediatrics|May 5, 2025
Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024Stephanie A Irving, Bradley Crane, Eric S Weintraub, et al.
MMWR. Morbidity and Mortality Weekly Report|February 21, 2020
Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020Fatimah S Dawood, Jessie R Chung, Sara S Kim, et al.
Pageof 25

Showing results (211-220 of 246) with videos related to

Sort By:
Pageof 25
The Journal of Infectious Diseases|January 24, 2018
Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United StatesBrendan Flannery, Catherine Smith, Rebecca J Garten, et al.
Journal of the American Geriatrics Society|April 20, 2010
Workshop on immunizations in older adults: identifying future research agendasKevin P High, Richard T D'Aquila, Rebecca A Fuldner, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
MMWR. Morbidity and Mortality Weekly Report|February 15, 2019
Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019Joshua D Doyle, Jessie R Chung, Sara S Kim, et al.
Vaccine|July 6, 2015
Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjectsSharon E Frey, Anna Wald, Srilatha Edupuganti, et al.
Science Translational Medicine|August 24, 2022
A genetically engineered <i>Plasmodium falciparum</i> parasite vaccine provides protection from controlled human malaria infectionSean C Murphy, Ashley M Vaughan, James G Kublin, et al.
NPJ Vaccines|June 2, 2026
Schistosomiasis vaccine SchistoShield® induces functional immune memory responses in US and African populationsMumtaz Y Balkhi, Aravindan Kalyanasundaram, Aryandra Arya, et al.
The Journal of Infectious Diseases|October 31, 2019
Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 SeasonBrendan Flannery, Rebecca J Garten Kondor, Jessie R Chung, et al.
Pediatrics|May 5, 2025
Infant Respiratory Syncytial Virus Immunization Coverage in the Vaccine Safety Datalink: 2023-2024Stephanie A Irving, Bradley Crane, Eric S Weintraub, et al.
MMWR. Morbidity and Mortality Weekly Report|February 21, 2020
Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020Fatimah S Dawood, Jessie R Chung, Sara S Kim, et al.
Pageof 25